
Novel ингибитор of against human liver FBPase (IC50, 0.029±0.006 μM) and high selectivity relative to the other six AMP-связывание enzymes, producing significant glucose-lowering effects on both type 2 diabetic KKAy mice and ZDF rats
Novel inhibitor of against human liver FBPase (IC50, 0.029±0.006 μM) and high selectivity relative to the other six AMP-binding enzymes, producing significant glucose-lowering effects on both type 2 diabetic KKAy mice and ZDF rats
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.